Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumoursJoão M. Fernandes Neto, René Bernards, Lourdes Farré et al.|Nature Communications|2020Cited by 93
Multiple Low Dose (MLD) therapy: an effective strategy to treat EGFR inhibitor-resistant NSCLC tumoursJoão M. Fernandes Neto, René Bernards|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 4